Clinical Trials Directory

Trials / Completed

CompletedNCT06811753

Impact of Robotic Surgery on Systemic Immune-inflammation Index

Impact of Robotic Surgery on Systemic Immune-inflammation Index in Gastric Cancer Patients

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Başakşehir Çam & Sakura City Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Robotic surgery has been gaining attention because of the physical and metabolic morbidity of the conventional open technique.The systemic immune-inflammation index(SII) has emerged as a recent and more reliable biomarker.In our single-center retrospective cohort study, the investigators investigate SII in robotic gastrectomy in order to show the advantageous effect on immune system which the investigators think as the first study in the literature.

Detailed description

Patients who underwent robotic gastrectomy between January 2021 and September 2024 were included in the study. The primary outcome was to ascertain the beneficial effects of robotic surgery in gastric cancer patients in terms of immune response. The secondary outcome was to examine the reliability of SII as a serum biomarker in comparison to previous studies on the diagnosis and postoperative follow-up of gastric cancer.

Conditions

Interventions

TypeNameDescription
PROCEDURErobotic surgeryminimally invasive surgery

Timeline

Start date
2023-12-01
Primary completion
2024-12-31
Completion
2025-01-01
First posted
2025-02-06
Last updated
2025-02-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06811753. Inclusion in this directory is not an endorsement.